Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancer
Phase 1
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000000978
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active infection 2. Severe peritoneal metastasis 3. Massive pleural effusion 4. CNS metastasis 5. Severe diarrhea 6. Suspected of Interstitial Pneumonitis 7. Other severe complications 8. Active malignancy 9. Pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method